Smith & Nephew plc (LON:SN) traded up 0% during mid-day trading on Thursday . The stock traded as high as GBX 1,326 ($17.44) and last traded at GBX 1,344 ($17.68). 2,050,291 shares were traded during mid-day trading, a decline of 44% from the average session volume of 3,640,000 shares. The stock had previously closed at GBX 1,344 ($17.68).

Several equities research analysts have recently issued reports on the company. Berenberg Bank reaffirmed a “hold” rating and issued a GBX 1,340 ($17.62) target price on shares of Smith & Nephew plc in a report on Friday, November 3rd. J P Morgan Chase & Co reduced their price objective on Smith & Nephew plc from GBX 1,382 ($18.18) to GBX 1,369 ($18.01) and set a “neutral” rating on the stock in a research note on Monday, November 13th. Jefferies Group LLC reissued a “buy” rating and set a GBX 1,515 ($19.93) price objective on shares of Smith & Nephew plc in a research note on Monday, November 6th. Deutsche Bank AG reissued a “hold” rating and set a GBX 1,200 ($15.78) price objective on shares of Smith & Nephew plc in a research note on Friday, July 28th. Finally, Citigroup Inc. reissued a “sell” rating and set a GBX 1,160 ($15.26) price objective on shares of Smith & Nephew plc in a research note on Thursday, October 12th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 1,302.83 ($17.14).

TRADEMARK VIOLATION NOTICE: This story was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/11/18/smith-nephew-plc-sn-trading-0-higher.html.

Smith & Nephew plc Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.